Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.01 | 40.66 |
PEG Ratio (TTM) | -0.01 | 5.42 |
P/S Ratio (TTM) | 1.71 | 6.33 |
P/B Ratio (TTM) | 0.01 | 5.87 |
P/FCF Ratio (TTM) | -0.29 | 37.81 |
Price to 5YR AVG Earnings Ratio | N/A | 59.41 |
Price to 5YR AVG FCF Ratio | N/A | 36.98 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -86.61% | 4.66% |
ROE (TTM) | -187.00% | 25.49% |
Net Profit Margin (TTM) | -648.92% | 7.22% |
ROIC 5YR AVG | N/A | 6.54% |
Growth (13%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 29.28% | -25.16% | N/A |
Revenue | -25.00% | N/A | N/A |
Net Income | 2.67% | -142.43% | N/A |
Cash Flow | -19.31% | -255.26% | N/A |
Health (46%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 4.38 | 2.64 |
Quick Ratio (TTM) | 4.38 | 1.97 |
D/E Ratio (TTM) | 0.05 | 0.55 |
Interest Coverage (TTM) | -9.77 | 2.38 |
Piotroski F-Score | 2 | 6 |
Altman Z-Score | N/A | 7.18 |
LTL to 5YR AVG FCF | N/A | 3.69 |
Shares Outstanding Growth 5YR AVG | N/A | 1.65% |